nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—esophageal cancer	0.803	1	CbGaD
Sitagliptin—Hepatic steatosis—Capecitabine—esophageal cancer	0.0044	0.0323	CcSEcCtD
Sitagliptin—Serum creatinine increased—Cisplatin—esophageal cancer	0.00293	0.0215	CcSEcCtD
Sitagliptin—Infection—Carboplatin—esophageal cancer	0.00218	0.016	CcSEcCtD
Sitagliptin—Serum creatinine increased—Capecitabine—esophageal cancer	0.00216	0.0158	CcSEcCtD
Sitagliptin—Cellulitis—Cisplatin—esophageal cancer	0.00198	0.0145	CcSEcCtD
Sitagliptin—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00197	0.0144	CcSEcCtD
Sitagliptin—Laryngeal pain—Capecitabine—esophageal cancer	0.00195	0.0143	CcSEcCtD
Sitagliptin—Pain—Carboplatin—esophageal cancer	0.00188	0.0137	CcSEcCtD
Sitagliptin—Herpes zoster—Capecitabine—esophageal cancer	0.00177	0.0129	CcSEcCtD
Sitagliptin—Contusion—Capecitabine—esophageal cancer	0.00152	0.0112	CcSEcCtD
Sitagliptin—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00147	0.0108	CcSEcCtD
Sitagliptin—Cellulitis—Capecitabine—esophageal cancer	0.00146	0.0107	CcSEcCtD
Sitagliptin—Renal failure acute—Cisplatin—esophageal cancer	0.00142	0.0104	CcSEcCtD
Sitagliptin—Lung disorder—Methotrexate—esophageal cancer	0.0014	0.0102	CcSEcCtD
Sitagliptin—Neck pain—Capecitabine—esophageal cancer	0.00135	0.00986	CcSEcCtD
Sitagliptin—Herpes zoster—Methotrexate—esophageal cancer	0.00131	0.00963	CcSEcCtD
Sitagliptin—Face oedema—Cisplatin—esophageal cancer	0.00126	0.00926	CcSEcCtD
Sitagliptin—Blood creatinine increased—Cisplatin—esophageal cancer	0.00123	0.00899	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.0012	0.00876	CcSEcCtD
Sitagliptin—Breast disorder—Cisplatin—esophageal cancer	0.00118	0.00867	CcSEcCtD
Sitagliptin—Nasopharyngitis—Cisplatin—esophageal cancer	0.00117	0.00858	CcSEcCtD
Sitagliptin—Pancreatitis—Cisplatin—esophageal cancer	0.00111	0.00813	CcSEcCtD
Sitagliptin—Gastroenteritis—Capecitabine—esophageal cancer	0.00109	0.00798	CcSEcCtD
Sitagliptin—Abdominal discomfort—Cisplatin—esophageal cancer	0.00108	0.00795	CcSEcCtD
Sitagliptin—Renal failure acute—Capecitabine—esophageal cancer	0.00105	0.00766	CcSEcCtD
Sitagliptin—Renal impairment—Capecitabine—esophageal cancer	0.00101	0.00743	CcSEcCtD
Sitagliptin—Renal failure—Cisplatin—esophageal cancer	0.000992	0.00727	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000989	0.00725	CcSEcCtD
Sitagliptin—Pain in extremity—Capecitabine—esophageal cancer	0.000965	0.00707	CcSEcCtD
Sitagliptin—Osteoarthritis—Capecitabine—esophageal cancer	0.000965	0.00707	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000954	0.00699	CcSEcCtD
Sitagliptin—Migraine—Capecitabine—esophageal cancer	0.00095	0.00696	CcSEcCtD
Sitagliptin—Face oedema—Capecitabine—esophageal cancer	0.000932	0.00683	CcSEcCtD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000921	0.0152	CbGpPWpGaD
Sitagliptin—Blood creatinine increased—Capecitabine—esophageal cancer	0.000904	0.00662	CcSEcCtD
Sitagliptin—Urinary tract disorder—Cisplatin—esophageal cancer	0.000894	0.00655	CcSEcCtD
Sitagliptin—Connective tissue disorder—Cisplatin—esophageal cancer	0.00089	0.00652	CcSEcCtD
Sitagliptin—Urethral disorder—Cisplatin—esophageal cancer	0.000888	0.0065	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000881	0.00646	CcSEcCtD
Sitagliptin—Abdominal pain upper—Capecitabine—esophageal cancer	0.000881	0.00646	CcSEcCtD
Sitagliptin—Breast disorder—Capecitabine—esophageal cancer	0.000872	0.00639	CcSEcCtD
Sitagliptin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000863	0.00632	CcSEcCtD
Sitagliptin—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.000856	0.0141	CbGpPWpGaD
Sitagliptin—Eye disorder—Cisplatin—esophageal cancer	0.000846	0.0062	CcSEcCtD
Sitagliptin—Cardiac disorder—Cisplatin—esophageal cancer	0.000841	0.00616	CcSEcCtD
Sitagliptin—Influenza—Capecitabine—esophageal cancer	0.000834	0.00611	CcSEcCtD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000822	0.0136	CbGpPWpGaD
Sitagliptin—Immune system disorder—Cisplatin—esophageal cancer	0.000818	0.00599	CcSEcCtD
Sitagliptin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000816	0.00598	CcSEcCtD
Sitagliptin—Bronchitis—Capecitabine—esophageal cancer	0.000802	0.00588	CcSEcCtD
Sitagliptin—Abdominal discomfort—Capecitabine—esophageal cancer	0.0008	0.00586	CcSEcCtD
Sitagliptin—Malnutrition—Cisplatin—esophageal cancer	0.000788	0.00578	CcSEcCtD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.000785	0.013	CbGpPWpGaD
Sitagliptin—Renal failure acute—Methotrexate—esophageal cancer	0.000778	0.0057	CcSEcCtD
Sitagliptin—Flatulence—Cisplatin—esophageal cancer	0.000777	0.00569	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000775	0.00568	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000766	0.0127	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000766	0.0127	CbGpPWpGaD
Sitagliptin—Weight increased—Capecitabine—esophageal cancer	0.000759	0.00556	CcSEcCtD
Sitagliptin—Muscle spasms—Cisplatin—esophageal cancer	0.000758	0.00555	CcSEcCtD
Sitagliptin—Hyperglycaemia—Capecitabine—esophageal cancer	0.000752	0.00551	CcSEcCtD
Sitagliptin—Pneumonia—Capecitabine—esophageal cancer	0.000748	0.00548	CcSEcCtD
Sitagliptin—Infestation—Capecitabine—esophageal cancer	0.000744	0.00545	CcSEcCtD
Sitagliptin—Infestation NOS—Capecitabine—esophageal cancer	0.000744	0.00545	CcSEcCtD
Sitagliptin—Vision blurred—Cisplatin—esophageal cancer	0.000743	0.00544	CcSEcCtD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000743	0.0123	CbGpPWpGaD
Sitagliptin—Depression—Capecitabine—esophageal cancer	0.000742	0.00543	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000737	0.0054	CcSEcCtD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000732	0.0121	CbGpPWpGaD
Sitagliptin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000732	0.00536	CcSEcCtD
Sitagliptin—Renal failure—Capecitabine—esophageal cancer	0.000731	0.00536	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000729	0.00534	CcSEcCtD
Sitagliptin—Urinary tract infection—Capecitabine—esophageal cancer	0.000723	0.0053	CcSEcCtD
Sitagliptin—Osteoarthritis—Methotrexate—esophageal cancer	0.000718	0.00526	CcSEcCtD
Sitagliptin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000717	0.0119	CbGpPWpGaD
Sitagliptin—Malaise—Cisplatin—esophageal cancer	0.000711	0.00521	CcSEcCtD
Sitagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00071	0.0117	CbGpPWpGaD
Sitagliptin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000703	0.00515	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000683	0.0113	CbGpPWpGaD
Sitagliptin—Myalgia—Cisplatin—esophageal cancer	0.000671	0.00492	CcSEcCtD
Sitagliptin—Anxiety—Cisplatin—esophageal cancer	0.000669	0.0049	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000667	0.00488	CcSEcCtD
Sitagliptin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000664	0.00487	CcSEcCtD
Sitagliptin—Discomfort—Cisplatin—esophageal cancer	0.000663	0.00486	CcSEcCtD
Sitagliptin—Pharyngitis—Capecitabine—esophageal cancer	0.000663	0.00485	CcSEcCtD
Sitagliptin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000659	0.00483	CcSEcCtD
Sitagliptin—Oedema peripheral—Capecitabine—esophageal cancer	0.000658	0.00482	CcSEcCtD
Sitagliptin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000656	0.00481	CcSEcCtD
Sitagliptin—Urethral disorder—Capecitabine—esophageal cancer	0.000654	0.00479	CcSEcCtD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000654	0.0108	CbGpPWpGaD
Sitagliptin—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000652	0.0108	CbGpPWpGaD
Sitagliptin—Breast disorder—Methotrexate—esophageal cancer	0.000649	0.00476	CcSEcCtD
Sitagliptin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000643	0.00471	CcSEcCtD
Sitagliptin—Infection—Cisplatin—esophageal cancer	0.000639	0.00468	CcSEcCtD
Sitagliptin—Erythema multiforme—Capecitabine—esophageal cancer	0.000631	0.00462	CcSEcCtD
Sitagliptin—Nervous system disorder—Cisplatin—esophageal cancer	0.000631	0.00462	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.000629	0.0104	CbGpPWpGaD
Sitagliptin—Skin disorder—Cisplatin—esophageal cancer	0.000625	0.00458	CcSEcCtD
Sitagliptin—Eye disorder—Capecitabine—esophageal cancer	0.000624	0.00457	CcSEcCtD
Sitagliptin—Cardiac disorder—Capecitabine—esophageal cancer	0.00062	0.00454	CcSEcCtD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000615	0.0102	CbGpPWpGaD
Sitagliptin—Pancreatitis—Methotrexate—esophageal cancer	0.000609	0.00446	CcSEcCtD
Sitagliptin—Angiopathy—Capecitabine—esophageal cancer	0.000606	0.00444	CcSEcCtD
Sitagliptin—Immune system disorder—Capecitabine—esophageal cancer	0.000603	0.00442	CcSEcCtD
Sitagliptin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000602	0.00441	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000595	0.00436	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000586	0.00429	CcSEcCtD
Sitagliptin—Mental disorder—Capecitabine—esophageal cancer	0.000585	0.00429	CcSEcCtD
Sitagliptin—Malnutrition—Capecitabine—esophageal cancer	0.000581	0.00426	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000577	0.00423	CcSEcCtD
Sitagliptin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000573	0.00948	CbGpPWpGaD
Sitagliptin—Flatulence—Capecitabine—esophageal cancer	0.000573	0.0042	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000572	0.00419	CcSEcCtD
Sitagliptin—Back pain—Capecitabine—esophageal cancer	0.000562	0.00412	CcSEcCtD
Sitagliptin—Decreased appetite—Cisplatin—esophageal cancer	0.000559	0.0041	CcSEcCtD
Sitagliptin—Muscle spasms—Capecitabine—esophageal cancer	0.000559	0.00409	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000558	0.00923	CbGpPWpGaD
Sitagliptin—Pneumonia—Methotrexate—esophageal cancer	0.000557	0.00408	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000556	0.00407	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000555	0.00918	CbGpPWpGaD
Sitagliptin—Infestation NOS—Methotrexate—esophageal cancer	0.000554	0.00406	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—esophageal cancer	0.000554	0.00406	CcSEcCtD
Sitagliptin—Depression—Methotrexate—esophageal cancer	0.000552	0.00404	CcSEcCtD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000551	0.00911	CbGpPWpGaD
Sitagliptin—Pain—Cisplatin—esophageal cancer	0.00055	0.00403	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000549	0.00402	CcSEcCtD
Sitagliptin—Vision blurred—Capecitabine—esophageal cancer	0.000548	0.00401	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—esophageal cancer	0.000544	0.00399	CcSEcCtD
Sitagliptin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000539	0.00395	CcSEcCtD
Sitagliptin—Feeling abnormal—Cisplatin—esophageal cancer	0.00053	0.00388	CcSEcCtD
Sitagliptin—Malaise—Capecitabine—esophageal cancer	0.000524	0.00384	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000524	0.00384	CcSEcCtD
Sitagliptin—Vertigo—Capecitabine—esophageal cancer	0.000522	0.00383	CcSEcCtD
Sitagliptin—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.000514	0.0085	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—XBP1—esophageal cancer	0.000512	0.00847	CbGpPWpGaD
Sitagliptin—Cough—Capecitabine—esophageal cancer	0.000507	0.00372	CcSEcCtD
Sitagliptin—Hypertension—Capecitabine—esophageal cancer	0.000502	0.00368	CcSEcCtD
Sitagliptin—Arthralgia—Capecitabine—esophageal cancer	0.000495	0.00362	CcSEcCtD
Sitagliptin—Myalgia—Capecitabine—esophageal cancer	0.000495	0.00362	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000495	0.00818	CbGpPWpGaD
Sitagliptin—Pharyngitis—Methotrexate—esophageal cancer	0.000493	0.00361	CcSEcCtD
Sitagliptin—Anxiety—Capecitabine—esophageal cancer	0.000493	0.00361	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000491	0.0036	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—SLC30A7—esophageal cancer	0.000491	0.00812	CbGpPWpGaD
Sitagliptin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000491	0.0036	CcSEcCtD
Sitagliptin—Discomfort—Capecitabine—esophageal cancer	0.000489	0.00358	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—esophageal cancer	0.000487	0.00357	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000487	0.00805	CbGpPWpGaD
Sitagliptin—Dry mouth—Capecitabine—esophageal cancer	0.000484	0.00355	CcSEcCtD
Sitagliptin—Hypersensitivity—Cisplatin—esophageal cancer	0.000474	0.00347	CcSEcCtD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000472	0.00781	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000472	0.00781	CbGpPWpGaD
Sitagliptin—Infection—Capecitabine—esophageal cancer	0.000471	0.00345	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—esophageal cancer	0.00047	0.00344	CcSEcCtD
Sitagliptin—Nervous system disorder—Capecitabine—esophageal cancer	0.000465	0.00341	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—esophageal cancer	0.000464	0.0034	CcSEcCtD
Sitagliptin—Asthenia—Cisplatin—esophageal cancer	0.000462	0.00338	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—esophageal cancer	0.000461	0.00338	CcSEcCtD
Sitagliptin—Skin disorder—Capecitabine—esophageal cancer	0.000461	0.00338	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000453	0.00748	CbGpPWpGaD
Sitagliptin—Angiopathy—Methotrexate—esophageal cancer	0.000451	0.0033	CcSEcCtD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000451	0.00746	CbGpPWpGaD
Sitagliptin—Immune system disorder—Methotrexate—esophageal cancer	0.000449	0.00329	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000448	0.00328	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000442	0.00731	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000442	0.0073	CbGpPWpGaD
Sitagliptin—Diarrhoea—Cisplatin—esophageal cancer	0.00044	0.00323	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.000436	0.00722	CbGpPWpGaD
Sitagliptin—Mental disorder—Methotrexate—esophageal cancer	0.000435	0.00319	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—esophageal cancer	0.000433	0.00317	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000432	0.00317	CcSEcCtD
Sitagliptin—Insomnia—Capecitabine—esophageal cancer	0.000429	0.00314	CcSEcCtD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000421	0.00696	CbGpPWpGaD
Sitagliptin—Back pain—Methotrexate—esophageal cancer	0.000419	0.00307	CcSEcCtD
Sitagliptin—Dyspepsia—Capecitabine—esophageal cancer	0.000418	0.00306	CcSEcCtD
Sitagliptin—Decreased appetite—Capecitabine—esophageal cancer	0.000412	0.00302	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00041	0.003	CcSEcCtD
Sitagliptin—Vomiting—Cisplatin—esophageal cancer	0.000409	0.003	CcSEcCtD
Sitagliptin—Fatigue—Capecitabine—esophageal cancer	0.000409	0.003	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—esophageal cancer	0.000408	0.00299	CcSEcCtD
Sitagliptin—Rash—Cisplatin—esophageal cancer	0.000406	0.00297	CcSEcCtD
Sitagliptin—Pain—Capecitabine—esophageal cancer	0.000406	0.00297	CcSEcCtD
Sitagliptin—Constipation—Capecitabine—esophageal cancer	0.000406	0.00297	CcSEcCtD
Sitagliptin—Dermatitis—Cisplatin—esophageal cancer	0.000405	0.00297	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000401	0.00294	CcSEcCtD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000399	0.00659	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000398	0.00658	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000393	0.00649	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Capecitabine—esophageal cancer	0.000391	0.00286	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—esophageal cancer	0.00039	0.00286	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—esophageal cancer	0.000389	0.00285	CcSEcCtD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000389	0.00643	CbGpPWpGaD
Sitagliptin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000388	0.00284	CcSEcCtD
Sitagliptin—Nausea—Cisplatin—esophageal cancer	0.000382	0.0028	CcSEcCtD
Sitagliptin—Cough—Methotrexate—esophageal cancer	0.000378	0.00277	CcSEcCtD
Sitagliptin—Urticaria—Capecitabine—esophageal cancer	0.000377	0.00276	CcSEcCtD
Sitagliptin—Abdominal pain—Capecitabine—esophageal cancer	0.000375	0.00275	CcSEcCtD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000371	0.00614	CbGpPWpGaD
Sitagliptin—Myalgia—Methotrexate—esophageal cancer	0.000368	0.0027	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—esophageal cancer	0.000368	0.0027	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000366	0.00268	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—esophageal cancer	0.000364	0.00267	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000353	0.00259	CcSEcCtD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000353	0.00584	CbGpPWpGaD
Sitagliptin—Infection—Methotrexate—esophageal cancer	0.000351	0.00257	CcSEcCtD
Sitagliptin—Hypersensitivity—Capecitabine—esophageal cancer	0.000349	0.00256	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—esophageal cancer	0.000346	0.00254	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000343	0.00567	CbGpPWpGaD
Sitagliptin—Skin disorder—Methotrexate—esophageal cancer	0.000343	0.00251	CcSEcCtD
Sitagliptin—Asthenia—Capecitabine—esophageal cancer	0.00034	0.00249	CcSEcCtD
Sitagliptin—Diarrhoea—Capecitabine—esophageal cancer	0.000325	0.00238	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000322	0.00533	CbGpPWpGaD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000322	0.00236	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000321	0.0053	CbGpPWpGaD
Sitagliptin—Insomnia—Methotrexate—esophageal cancer	0.000319	0.00234	CcSEcCtD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000316	0.00523	CbGpPWpGaD
Sitagliptin—Somnolence—Methotrexate—esophageal cancer	0.000314	0.0023	CcSEcCtD
Sitagliptin—Dizziness—Capecitabine—esophageal cancer	0.000314	0.0023	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—esophageal cancer	0.000311	0.00228	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—esophageal cancer	0.000307	0.00225	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000306	0.00506	CbGpPWpGaD
Sitagliptin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000305	0.00223	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—ACTB—esophageal cancer	0.000304	0.00504	CbGpPWpGaD
Sitagliptin—Fatigue—Methotrexate—esophageal cancer	0.000304	0.00223	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000304	0.00503	CbGpPWpGaD
Sitagliptin—Pain—Methotrexate—esophageal cancer	0.000302	0.00221	CcSEcCtD
Sitagliptin—Vomiting—Capecitabine—esophageal cancer	0.000302	0.00221	CcSEcCtD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000301	0.00499	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.0003	0.00496	CbGpPWpGaD
Sitagliptin—Rash—Capecitabine—esophageal cancer	0.000299	0.00219	CcSEcCtD
Sitagliptin—Dermatitis—Capecitabine—esophageal cancer	0.000299	0.00219	CcSEcCtD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000298	0.00493	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000298	0.00492	CbGpPWpGaD
Sitagliptin—Headache—Capecitabine—esophageal cancer	0.000297	0.00218	CcSEcCtD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000296	0.00489	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—ADH7—esophageal cancer	0.000295	0.00488	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Methotrexate—esophageal cancer	0.000291	0.00213	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000289	0.00212	CcSEcCtD
Sitagliptin—Nausea—Capecitabine—esophageal cancer	0.000282	0.00206	CcSEcCtD
Sitagliptin—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000281	0.00465	CbGpPWpGaD
Sitagliptin—Urticaria—Methotrexate—esophageal cancer	0.000281	0.00206	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000279	0.00462	CbGpPWpGaD
Sitagliptin—Abdominal pain—Methotrexate—esophageal cancer	0.000279	0.00204	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—HSPA5—esophageal cancer	0.000275	0.00455	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CALR—esophageal cancer	0.000267	0.00441	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—GHRL—esophageal cancer	0.000262	0.00433	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000261	0.00432	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Methotrexate—esophageal cancer	0.00026	0.00191	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00026	0.0043	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—ADH1B—esophageal cancer	0.000259	0.00428	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—FBXW7—esophageal cancer	0.000258	0.00426	CbGpPWpGaD
Sitagliptin—Asthenia—Methotrexate—esophageal cancer	0.000253	0.00186	CcSEcCtD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000244	0.00404	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000243	0.00402	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000242	0.004	CbGpPWpGaD
Sitagliptin—Diarrhoea—Methotrexate—esophageal cancer	0.000242	0.00177	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—CYP26A1—esophageal cancer	0.00024	0.00398	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000237	0.00392	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000234	0.00388	CbGpPWpGaD
Sitagliptin—Dizziness—Methotrexate—esophageal cancer	0.000234	0.00171	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—esophageal cancer	0.000225	0.00164	CcSEcCtD
Sitagliptin—CYP2C8—Biological oxidations—GSTO1—esophageal cancer	0.000223	0.0037	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000223	0.00369	CbGpPWpGaD
Sitagliptin—Rash—Methotrexate—esophageal cancer	0.000223	0.00163	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—esophageal cancer	0.000222	0.00163	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000222	0.00367	CbGpPWpGaD
Sitagliptin—Headache—Methotrexate—esophageal cancer	0.000221	0.00162	CcSEcCtD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTO1—esophageal cancer	0.00022	0.00365	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000214	0.00353	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000213	0.00352	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000213	0.00352	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000211	0.00348	CbGpPWpGaD
Sitagliptin—Nausea—Methotrexate—esophageal cancer	0.00021	0.00154	CcSEcCtD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.0002	0.00331	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000188	0.0031	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000184	0.00304	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—ALDH2—esophageal cancer	0.000182	0.00301	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000174	0.00288	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTT1—esophageal cancer	0.000173	0.00287	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000173	0.00286	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000172	0.00285	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP2A6—esophageal cancer	0.000171	0.00283	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00017	0.00281	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000167	0.00277	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000164	0.00271	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—PTGS1—esophageal cancer	0.000162	0.00269	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000162	0.00268	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00016	0.00264	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000159	0.00262	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000158	0.00262	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000142	0.00236	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00014	0.00231	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000139	0.0023	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1B1—esophageal cancer	0.000138	0.00228	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000136	0.00225	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000133	0.0022	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000131	0.00217	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP19A1—esophageal cancer	0.00013	0.00215	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000129	0.00213	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000128	0.00212	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000128	0.00211	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000127	0.0021	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.000124	0.00205	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00012	0.00198	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000118	0.00196	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000117	0.00193	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000111	0.00184	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00011	0.00182	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000107	0.00177	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000104	0.00172	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.83e-05	0.00163	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	9.78e-05	0.00162	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	9.7e-05	0.0016	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	9.41e-05	0.00156	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.38e-05	0.00155	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	9.3e-05	0.00154	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	9.19e-05	0.00152	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	9.11e-05	0.00151	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	9e-05	0.00149	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.99e-05	0.00149	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.99e-05	0.00149	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	8.72e-05	0.00144	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	8.62e-05	0.00143	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.85e-05	0.0013	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	7.41e-05	0.00123	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	7.31e-05	0.00121	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BLVRB—esophageal cancer	6.98e-05	0.00115	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC52A3—esophageal cancer	6.98e-05	0.00115	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	6.97e-05	0.00115	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	6.87e-05	0.00114	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.82e-05	0.00113	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.24e-05	0.00103	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.18e-05	0.00102	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.12e-05	0.00101	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.09e-05	0.00101	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC52A3—esophageal cancer	6.08e-05	0.00101	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BLVRB—esophageal cancer	6.08e-05	0.00101	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA1—esophageal cancer	5.93e-05	0.000981	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC10A2—esophageal cancer	5.93e-05	0.000981	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA2—esophageal cancer	5.42e-05	0.000897	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.3e-05	0.000877	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.25e-05	0.000868	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA1—esophageal cancer	5.17e-05	0.000855	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC10A2—esophageal cancer	5.17e-05	0.000855	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.1e-05	0.000843	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PLCE1—esophageal cancer	5.04e-05	0.000834	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ADH7—esophageal cancer	5.04e-05	0.000834	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.99e-05	0.000824	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.99e-05	0.000824	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA2—esophageal cancer	4.73e-05	0.000782	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.5e-05	0.000745	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ADH1B—esophageal cancer	4.42e-05	0.000731	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PLCE1—esophageal cancer	4.39e-05	0.000727	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ADH7—esophageal cancer	4.39e-05	0.000727	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.36e-05	0.000721	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMP—esophageal cancer	4.23e-05	0.000699	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.15e-05	0.000686	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP26A1—esophageal cancer	4.11e-05	0.00068	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALOX15—esophageal cancer	4.01e-05	0.000663	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ADH1B—esophageal cancer	3.85e-05	0.000637	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.82e-05	0.000632	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TPI1—esophageal cancer	3.82e-05	0.000632	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.77e-05	0.000623	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.74e-05	0.000619	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.74e-05	0.000619	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMP—esophageal cancer	3.68e-05	0.000609	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.66e-05	0.000606	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.61e-05	0.000598	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.58e-05	0.000592	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.53e-05	0.000584	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.53e-05	0.000583	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.5e-05	0.000578	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALOX15—esophageal cancer	3.49e-05	0.000577	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTO1—esophageal cancer	3.33e-05	0.000551	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TPI1—esophageal cancer	3.33e-05	0.000551	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GNG7—esophageal cancer	3.33e-05	0.00055	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDOB—esophageal cancer	3.19e-05	0.000528	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA1—esophageal cancer	3.18e-05	0.000527	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.18e-05	0.000527	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDH2—esophageal cancer	3.12e-05	0.000515	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GAPDH—esophageal cancer	3.07e-05	0.000508	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.07e-05	0.000507	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CRABP1—esophageal cancer	3.05e-05	0.000504	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.97e-05	0.000491	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.96e-05	0.00049	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.93e-05	0.000484	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.92e-05	0.000483	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA2—esophageal cancer	2.91e-05	0.000482	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GNG7—esophageal cancer	2.9e-05	0.000479	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ENO1—esophageal cancer	2.78e-05	0.000459	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.78e-05	0.000459	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSME2—esophageal cancer	2.74e-05	0.000453	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PSME1—esophageal cancer	2.74e-05	0.000453	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDH2—esophageal cancer	2.71e-05	0.000449	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.71e-05	0.000448	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ADH7—esophageal cancer	2.71e-05	0.000448	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—esophageal cancer	2.58e-05	0.000427	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.55e-05	0.000422	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ENO1—esophageal cancer	2.42e-05	0.0004	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS1—esophageal cancer	2.42e-05	0.0004	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.42e-05	0.0004	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.39e-05	0.000395	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSME2—esophageal cancer	2.38e-05	0.000394	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PSME1—esophageal cancer	2.38e-05	0.000394	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.37e-05	0.000393	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.36e-05	0.000391	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMP—esophageal cancer	2.27e-05	0.000375	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.22e-05	0.000367	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.21e-05	0.000365	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.15e-05	0.000356	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.06e-05	0.00034	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TPI1—esophageal cancer	2.05e-05	0.000339	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.05e-05	0.000339	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.03e-05	0.000335	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.99e-05	0.000329	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.97e-05	0.000325	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.94e-05	0.000322	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.93e-05	0.00032	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.89e-05	0.000313	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.88e-05	0.00031	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.78e-05	0.000295	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMOX1—esophageal cancer	1.76e-05	0.000292	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.67e-05	0.000277	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.59e-05	0.000263	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.57e-05	0.00026	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.49e-05	0.000247	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.49e-05	0.000247	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.47e-05	0.000243	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.47e-05	0.000243	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.47e-05	0.000243	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.3e-05	0.000215	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.27e-05	0.00021	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.19e-05	0.000197	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NOS3—esophageal cancer	1.16e-05	0.000192	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CREBBP—esophageal cancer	1.13e-05	0.000187	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.09e-05	0.00018	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.06e-05	0.000176	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.04e-05	0.000173	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NOS3—esophageal cancer	1.01e-05	0.000168	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—esophageal cancer	9.27e-06	0.000153	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—EP300—esophageal cancer	8.85e-06	0.000146	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—EP300—esophageal cancer	7.71e-06	0.000128	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.98e-06	0.000115	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—esophageal cancer	6.55e-06	0.000108	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NOS3—esophageal cancer	6.25e-06	0.000103	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.71e-06	9.45e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.7e-06	9.43e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—EP300—esophageal cancer	4.75e-06	7.86e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.51e-06	5.81e-05	CbGpPWpGaD
